Dr. Russell Kerschmann is an M.D. pathologist with over 30 years experience in executive management, clinical practice, biomedical device development, and the molecular pathology industries. During his career he has served on the faculties of Harvard Medical School, the University of Massachusetts, and the University of California at San Francisco. In 1997, he founded and served as CEO of a medical device company, Resolution Sciences, which produced an innovative award-winning digital microscopy technology and received financing from venture capital and Asian angel investors. From 2004 to 2009, he was Senior Executive Service manager of the Space Biosciences program at NASA Ames Research Center, where he initiated programs in radiation biology and toxicology and significantly increased the program’s funding. Subsequently, he served for a decade on the NASA Engineering and Safety Center and as an Ames Associate. Following his full-time tenure at NASA, he became the CLIA Medical Director of the San Francisco Bay business unit of Quest Diagnostics, the largest commercial clinical laboratory in the U.S. He currently holds CLIA/CAP medical directorships at several California laboratories, including Ascend Clinical, Octave Bioscience, Notable Labs, and Grail, Inc., and is the signing pathologist responsible for the medical quality of about 30 million laboratory tests annually. Dr. Kerschmann’s undergraduate education centered on electrical engineering and neurosciences. He earned his medical degree from the University of Massachusetts, and did his residency training at Massachusetts General Hospital.